Page last updated: 2024-11-04

sulfadiazine and Leukemia, Myeloid

sulfadiazine has been researched along with Leukemia, Myeloid in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saad, R1
Vincent, JF1
Cimon, B1
de Gentile, L1
Francois, S1
Bouachour, G1
Ifrah, N1
Masson, R1
Fière, D1
Lahnèche, B1
Cordat, C1
Berger, F1
Revol, L1

Reviews

1 review available for sulfadiazine and Leukemia, Myeloid

ArticleYear
Pulmonary toxoplasmosis after allogeneic bone marrow transplantation: case report and review.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Acute Disease; Adult; Animals; Antibodies, Protozoan; Antineoplastic Combined Chemotherapy Protocols

1996

Other Studies

1 other study available for sulfadiazine and Leukemia, Myeloid

ArticleYear
[Encephalic pseudotumoral toxoplasmosis in the course of blood diseases].
    La Nouvelle presse medicale, 1975, Oct-18, Volume: 4, Issue:35

    Topics: Brain; Brain Diseases; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Immunosuppression

1975